Key Insights

Highlights

Success Rate

82% trial completion

Published Results

34 trials with published results (23%)

Research Maturity

85 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

12.6%

19 terminated out of 151 trials

Success Rate

81.7%

-4.8% vs benchmark

Late-Stage Pipeline

14%

21 trials in Phase 3/4

Results Transparency

40%

34 of 85 completed with results

Key Signals

34 with results82% success19 terminated

Data Visualizations

Phase Distribution

116Total
Not Applicable (48)
Early P 1 (3)
P 1 (12)
P 2 (32)
P 3 (10)
P 4 (11)

Trial Status

Completed85
Terminated19
Unknown17
Recruiting14
Withdrawn9
Active Not Recruiting3

Trial Success Rate

81.7%

Benchmark: 86.5%

Based on 85 completed trials

Clinical Trials (151)

Showing 20 of 20 trials
NCT04734106Early Phase 1RecruitingPrimary

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

NCT06013449Not ApplicableWithdrawnPrimary

Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations

NCT07698626Phase 1Not Yet Recruiting

Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome

NCT04450316Phase 2Terminated

Low-dose Naltrexone for Bladder Pain Syndrome

NCT06232200Not ApplicableCompletedPrimary

Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis

NCT04734847Not ApplicableActive Not RecruitingPrimary

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

NCT00499317Recruiting

Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

NCT06096597Phase 2RecruitingPrimary

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

NCT05149573Not ApplicableRecruitingPrimary

Investigation of PEMF Therapy for Female Patients With IC/BPS

NCT05658874Phase 3TerminatedPrimary

A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain

NCT03844412Phase 2Completed

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

NCT02591199Phase 2TerminatedPrimary

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

NCT05127616Not ApplicableRecruiting

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

NCT05737121Phase 2RecruitingPrimary

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

NCT06394830Phase 2RecruitingPrimary

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

NCT06299683Not ApplicableRecruiting

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

NCT00124306Phase 3Completed

Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)

NCT06366269Not ApplicableRecruiting

Acupuncture First for IC/BPS

NCT00389142RecruitingPrimary

Identifying Genetic Causes of IC/BPS

NCT05726786Phase 3Recruiting

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Scroll to load more

Research Network

Activity Timeline